TNGX Tango Therapeutics, Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
17:50
Aug 26
seedy19tron
TNGX dismissed as junk investment
Author explicitly dismisses TNGX as being in the junk pile, a bearish do-not-own view without an explicit short position.
TNGX Tango Therapeutics, Inc. Avoid — —
13:58
Aug 12
psyduckcapital
Initiated starter position in TNGX
Opens a new starter position in $TNGX, a small initial long stake; no rationale stated alongside the trade.
TNGX Tango Therapeutics, Inc. Long 1ST Position: Opened —
13:13
Jun 21
seedy19tron
Buy ERAS and TNGX as explicit M&A candidates in the RAS/oncology space.
Buy ERAS and TNGX as explicit M&A candidates in the RAS/oncology space; author identifies them as "in play" given the current wave of radiopharmaceutical and oncology deal activity, with ERAS at ~5.2 months post positive data squarely in the historical acquisition window.
TNGX Tango Therapeutics, Inc. Long — —
Log in to see ideas

About TNGX Investor Commentary

Across the available history and selected sources, Buzzberg tracks TNGX (Tango Therapeutics, Inc.) across 6 sources: 4 bullish vs 0 bearish calls from 6 authors. Historical directional balance: 31% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 13 total trade ideas tracked. Latest voices: seedy19tron, psyduckcapital.